Osteoprotegerin and Denosumab Stimulate Human Beta Cell Proliferation through Inhibition of the Receptor Activator of NF-κB Ligand Pathway.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Cell Metabolism

• Publication date

  2015-07-07

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.cmet.2015.05.021PMID 26094891PMCID PMC4597781
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diabetes, Collagen, and Bone Quality

  2014cited by this paper
• Effects of antiresorptive therapies on glucose metabolism: Results from the FIT, HORIZON‐PFT, and FREEDOM trials

  2013cited by this paper
• Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus

  2013cited by this paper
• The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells

  2013cited by this paper
• Lactogens protect rodent and human beta cells against glucolipotoxicity-induced cell death through Janus kinase‐2 (JAK2)/signal transducer and activator of transcription-5 (STAT5) signalling

  2012cited by this paper
• Human β-Cell Proliferation and Intracellular Signaling

  2012cited by this paper
• Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets.

  2011cited by this paper
• Systemic and acute administration of parathyroid hormone-related peptide(1–36) stimulates endogenous beta cell proliferation while preserving function in adult mice

  2011cited by this paper
• Growth Factor Mediated Regulation of Beta Cell Survival

  2010cited by this paper
• Bone disease in diabetes.

  2010cited by this paper
• Expansion of beta-cell mass in response to pregnancy.

  2010cited by this paper
• Physiology and pathophysiology of the RANKL/RANK system

  2010cited by this paper
• Significant human beta-cell turnover is limited to the first three decades of life as determined by in vivo thymidine analog incorporation and radiocarbon dating.

  2010cited by this paper
• One Year of Transgenic Overexpression of Osteoprotegerin in Rats Suppressed Bone Resorption and Increased Vertebral Bone Volume, Density, and Strength

  2009cited by this paper
• Denosumab: Anti-RANKL antibody

  2009cited by this paper
• The transcriptional response of the islet to pregnancy in mice.

  2009cited by this paper
• Denosumab, a Fully Human Monoclonal Antibody to RANKL, Inhibits Bone Resorption and Increases BMD in Knock‐In Mice That Express Chimeric (Murine/Human) RANKL

  2009cited by this paper
• Prolactin receptor is required for normal glucose homeostasis and modulation of beta-cell mass during pregnancy.

  2009cited by this paper
• Detailed transcriptome atlas of the pancreatic beta cell

  2009cited by this paper
• Glycogen Synthase Kinase-3 and Mammalian Target of Rapamycin Pathways Contribute to DNA Synthesis, Cell Cycle Progression, and Proliferation in Human Islets

  2009cited by this paper
• Minireview: Meeting the demand for insulin: molecular mechanisms of adaptive postnatal beta-cell mass expansion.

  2009cited by this paper
• Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.

  2008cited by this paper
• Cytokine-induced osteoprotegerin expression protects pancreatic beta cells through p38 mitogen-activated protein kinase signalling against cell death

  2007cited by this paper
• Protein Kinase C-ζ Activation Markedly Enhances β-Cell Proliferation

  2007cited by this paper
• Lactogens Promote Beta Cell Survival through JAK2/STAT5 Activation and Bcl-XL Upregulation*

  2007cited by this paper
• Proliferation of sorted human and rat beta cells

  2007cited by this paper
• Investigating the interaction between osteoprotegerin and receptor activator of NF-kappaB or tumor necrosis factor-related apoptosis-inducing ligand: evidence for a pivotal role for osteoprotegerin in regulating two distinct pathways.

  2007cited by this paper
• Protein kinase C-zeta activation markedly enhances beta-cell proliferation: an essential role in growth factor mediated beta-cell mitogenesis.

  2007cited by this paper
• Growth factors and beta cell replication.

  2006cited by this paper
• Increased Pancreatic β-Cell Proliferation Mediated by CREB Binding Protein Gene Activation

  2006cited by this paper
• Gene transfer of constitutively active Akt markedly improves human islet transplant outcomes in diabetic severe combined immunodeficient mice.

  2005cited by this paper
• Maternal plasma osteoprotegerin concentration in normal pregnancy.

  2005cited by this paper
• Very Slow Turnover of β-Cells in Aged Adult Mice

  2005cited by this paper
• Very slow turnover of beta-cells in aged adult mice.

  2005cited by this paper
• Characterization of mice doubly transgenic for parathyroid hormone-related protein and murine placental lactogen: a novel role for placental lactogen in pancreatic beta-cell survival.

  2004cited by this paper
• Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation.

  2004cited by this paper
• Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation

  2004cited by this paper
• Targeted deletion of the PRL receptor: effects on islet development, insulin production, and glucose tolerance.

  2002cited by this paper
• Osteoclastogenesis inhibitory factor/osteoprotegerin ameliorates the decrease in both bone mineral density and bone strength in immobilized rats

  2002cited by this paper
• Targeted Expression of Placental Lactogen in the Beta Cells of Transgenic Mice Results in Beta Cell Proliferation, Islet Mass Augmentation, and Hypoglycemia*

  2000cited by this paper
• Sustained proliferation of PDX-1+ cells derived from human islets.

  1999cited by this paper
• Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

  1997cited by this paper
• Multiple low-dose streptozotocin-induced hyperglycemia and insulitis in C57BL mice: influence of inbred background, sex, and thymus.

  1982cited by this paper
• Annals of the New York Academy of Sciences the Role of Reactive Oxygen Species and Proinflammatory Cytokines in Type 1 Diabetes Pathogenesis

  year unknowncited by this paper
• Annals of the New York Academy of Sciences Islet ␤ Cell Mass in Diabetes and How It Relates to Function, Birth, and Death

  year unknowncited by this paper

• Integration of metabolomics and transcriptomics to reveal metabolic characteristics and the role of mTORC1 in β-cell proliferation induced by a short-term high-fat diet.

  2026cites this paper
• Smart biomaterials for skeletal aging repair and regeneration

  2026cites this paper
• Regenerative medicine approaches for treating diabetes: Current advances and future directions.

  2025cites this paper
• A Microphysiological Interface of Skeletal Myobundles and Inflamed Adipose Tissue for Recapitulating Muscle Dysfunction in an Obese Microenvironment

  2025cites this paper
• Proinflammatory circulating extracellular vesicles from type 1 diabetes patients contribute to beta cell cytotoxicity and disease pathogenicity

  2025cites this paper
• Effects of metformin and Denosumab on bone and glucose metabolism in postmenopausal women with OP and OA.

  2025cites this paper
• Drug-induced regeneration of pancreatic beta cells: An approach to cellular therapeutic targets

  2025cites this paper
• The role of bone in whole-body energy metabolism

  2025cites this paper
• From Bone Health to Lifespan: Pleiotropic Effects of Antiresorptive Agents

  2025cites this paper
• Transcriptomic modifications in maternal pancreatic islets during the period around weaning in mice.

  2025cites this paper
• Advances in the management of osteoporosis

  2025cites this paper
• Harnessing beta-cell replication: advancing molecular insights to regenerative therapies in diabetes

  2025cites this paper
• RSPO1, a potent inducer of pancreatic β cell neogenesis

  2025cites this paper
• Ribonuclease 4 is a pancreatic endogenous β cell proliferation factor.

  2025cites this paper
• Beyond Bone Remodeling: Denosumab’s Multisystemic Benefits in Musculoskeletal Health, Metabolism, and Age-Related Diseases—A Narrative Review

  2025cites this paper
• Liver-derived Neuregulin1α stimulates compensatory pancreatic β cell hyperplasia in insulin resistance

  2025cites this paper
• Research Progress on the Influence of Novel Targeted Drugs for Osteoporosis on Glucose Metabolism

  2025cites this paper
• Islet single-cell transcriptomic profiling during obesity-induced beta cell expansion in female mice

  2025cites this paper
• The effects of type 1 and type 2 diabetes mellitus on bone health in chronic kidney disease

  2025cites this paper
• Recent Advances in Promoting Bone Regeneration in Type 2 Diabetes Using Drug Delivery Vehicles and Vehicle‐Free Therapeutics

  2025cites this paper
• LGR4 is essential for maintaining β-cell homeostasis through suppression of RANK

  2025cites this paper
• Promotion of beta cell proliferation through DYRK kinase inhibition using the marine natural product breitfussin C

  2025cites this paper
• Mechanistic analysis of abnormal activation of the RANKL-RANK signaling axis in diabetic bone injury

  2025cites this paper
• The role of bone in energy metabolism: A focus on osteocalcin.

  2024cites this paper
• Extra-osseous Roles of the RANK-RANKL-OPG Axis with a Focus on Skeletal Muscle

  2024cites this paper
• Bone Fragility in Diabetes and its Management: A Narrative Review

  2024cites this paper
• Metabolic factors are not the direct mediators of the association between type 2 diabetes and osteoporosis

  2024cites this paper
• Type 2 diabetes incidence in patients initiating denosumab or alendronate treatment: a primary care cohort study

  2024influential citation
• Denosumab, for osteoporosis, reduces the incidence of type 2 diabetes, risk of foot ulceration and all‐cause mortality in adults, compared with bisphosphonates: An analysis of real‐world, cohort data, with a systematic review and meta‐analysis

  2024cites this paper
• FAM19A5 in vascular aging and osteoporosis: mechanisms and the "calcification paradox".

  2024cites this paper
• Ethnic Variations in the Levels of Bone Biomarkers (Osteoprostegerin, Receptor Activator of Nuclear Factor Kappa-Β Ligand and Glycoprotein Non-Metastatic Melanoma Protein B) in People with Type 2 Diabetes

  2024cites this paper
• Harnessing beta cell regeneration biology for diabetes therapy.

  2024cites this paper
• Denosumab - protection for bone and beyond?

  2024cites this paper
• Gut-Derived Peptide Hormone Analogues and Potential Treatment of Bone Disorders in Obesity and Diabetes Mellitus

  2024cites this paper
• Pancreatic β-cell failure, clinical implications, and therapeutic strategies in type 2 diabetes

  2024cites this paper
• Prolactin effects on the pathogenesis of diabetes mellitus

  2024cites this paper
• Denosumab and the Risk of Diabetes in Patients Treated for Osteoporosis

  2024cites this paper
• The Role of the Receptor Activator of Nuclear Factor Kappa-B Ligand/Osteoprotegerin Ratio in Vascular Diseases: A Therapeutic Approach

  2024cites this paper
• Effect of denosumab on glucose metabolism in postmenopausal osteoporotic women with prediabetes: a study protocol for a 12-month multicenter, open-label, randomized controlled trial

  2023cites this paper
• Signaling pathways that regulate adaptive β‐cell proliferation for the treatment of diabetes

  2023cites this paper
• Association between dietary selenium intake and the prevalence of osteoporosis and its role in the treatment of glucocorticoid-induced osteoporosis

  2023cites this paper
• RANKL/RANK is required for cytokine-induced beta cell death; osteoprotegerin, a RANKL inhibitor, reverses rodent type 1 diabetes

  2023cites this paper
• Talin-1 inhibits Smurf1-mediated Stat3 degradation to modulate β-cell proliferation and mass in mice

  2023cites this paper
• Prolactin in Polycystic Ovary Syndrome: Metabolic Effects and Therapeutic Prospects

  2023cites this paper
• OPG gene-modified adipose-derived stem cells improve bone formation around implants in osteoporotic rat maxillae

  2023cites this paper
• Evidence in Humans for Bone as an Endocrine Organ Regulating Energy Metabolism.

  2023cites this paper
• Crosstalk between the neuroendocrine system and bone homeostasis.

  2023cites this paper
• Denosumab Attenuates Glucolipotoxicity-Induced β-Cell Dysfunction and Apoptosis by Attenuating RANK/RANKL Signals

  2023influential citation
• Excess pancreatic elastase alters acinar-β cell communication by impairing the mechano-signaling and the PAR2 pathways.

  2023cites this paper
• RANKL inhibition: a new target of treating diabetes mellitus?

  2023cites this paper
• Osteoprotegerin/Receptor Activator of Nuclear Factor-Kappa B Ligand/Receptor Activator of Nuclear Factor-Kappa B Axis in Obesity, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease

  2023cites this paper
• Denosumab and incidence of type 2 diabetes among adults with osteoporosis: population based cohort study

  2023cites this paper
• Obesity, but not high-fat diet, is associated with bone loss that is reversed via CD4+CD25+Foxp3+ Tregs-mediated gut microbiome of non-obese mice

  2023cites this paper
• Crosstalk Communications Between Islets Cells and Insulin Target Tissue: The Hidden Face of Iceberg

  2022cites this paper
• Limited extent and consequences of pancreatic SARS-CoV-2 infection

  2022cites this paper
• Regeneration of Pancreatic β-Cells for Diabetes Therapeutics by Natural DYRK1A Inhibitors

  2022cites this paper
• Therapeutic strategies targeting pancreatic islet β-cell proliferation, regeneration, and replacement.

  2022cites this paper
• Roles of osteoprotegerin in endocrine and metabolic disorders through receptor activator of nuclear factor kappa-B ligand/receptor activator of nuclear factor kappa-B signaling

  2022cites this paper
• The Key Role of Bone Function Markers in Patients with Type (II) Diabetes Mellitus

  2022cites this paper
• E2F1 transcription factor mediates a link between fat and islets to promote β cell proliferation in response to acute insulin resistance

  2022cites this paper
• The beneficial metabolic actions of prolactin

  2022cites this paper
• Targeting pancreatic β cells for diabetes treatment

  2022cites this paper
• IL18 signaling causes islet β cell development and insulin secretion via different receptors on acinar and β cells.

  2022cites this paper
• Emerging diabetes therapies: Bringing back the β-cells

  2022cites this paper
• Study The Association between Serum Osteoprotegerin and Diabetic Kidney Disease

  2022cites this paper
• Mitogen Synergy: An Emerging Route to Boosting Human Beta Cell Proliferation

  2022cites this paper
• DMSO_A_288338 671..682

  2021cites this paper
• Overexpression of miR125b Promotes Osteoporosis Through miR-125b-TRAF6 Pathway in Postmenopausal Ovariectomized Rats

  2021cites this paper
• Global Deletion of the Prolactin Receptor Aggravates Streptozotocin-Induced Diabetes in Mice

  2021cites this paper
• DYRK1A Inhibitors as Potential Therapeutics for β-Cell Regeneration for Diabetes.

  2021cites this paper
• The Impact of Antiosteoporotic Drugs on Glucose Metabolism and Fracture Risk in Diabetes: Good or Bad News?

  2021cites this paper
• Endocrine role of bone in the regulation of energy metabolism

  2021cites this paper
• Mechanisms of altered bone remodeling in children with type 1 diabetes

  2021cites this paper
• Debates in Pancreatic Beta Cell Biology: Proliferation Versus Progenitor Differentiation and Transdifferentiation in Restoring β Cell Mass

  2021cites this paper
• Sulfonylureas for Treatment of Periodontitis-Diabetes Comorbidity-Related Complications: Killing Two Birds With One Stone

  2021cites this paper
• Osteoprotegerin expression and serum values in obese women with type 2 diabetes mellitus

  2021cites this paper
• Vertical sleeve gastrectomy triggers fast β-cell recovery upon overt diabetes

  2021cites this paper
• Update on the pathogenesis and treatment of skeletal fragility in type 2 diabetes mellitus

  2021cites this paper
• Protection factors used to improve in vivo islet function

  2021cites this paper
• Osteoporose bei Diabetes mellitus

  2021cites this paper
• Denosumab improves glucose parameters in patients with impaired glucose tolerance: a systematic review and meta-analysis

  2021cites this paper
• New Recommendations for T2D Management: Beneficial Impact of Exerkines on Pancreatic ?-Cells Function and Glucose Homeostasis in Skeletal Muscle

  2021influential citation
• Strategies to promote beta-cell replication and regeneration

  2020cites this paper
• The 2039 A/G FSH receptor gene polymorphism influences glucose metabolism in healthy men

  2020cites this paper
• Relationship between GDF15 level and bone metabolism in postmenopausal Chinese women

  2020cites this paper
• Positive Effect of Gushukang on Type-H Vessel and Bone Formation

  2020cites this paper
• Architecture of bone tissue and its adaptation to pathological conditions

  2020cites this paper
• The endocrine role of bone: Novel functions of bone-derived cytokines.

  2020cites this paper
• How Different Are the Molecular Mechanisms of Nodal and Distant Metastasis in Luminal A Breast Cancer?

  2020cites this paper
• Comparative efficacy between monoclonal antibodies and conventional drugs in postmenopausal women with osteoporosis: a network meta-analysis.

  2020cites this paper
• Diabetes mellitus: How being too sweet leads to skeletal fragility

  2020cites this paper
• Pharmacological mechanisms of therapeutics

  2020cites this paper
• Placenta-Derived Osteoprotegerin Is Required for Glucose Homeostasis in Gestational Diabetes Mellitus

  2020cites this paper
• MiR-151a-3p Promotes Postmenopausal Osteoporosis by Targeting SOCS5 and Activating JAK2/STAT3 Signaling

  2020cites this paper
• Effect of Denosumab on Glucose Homeostasis in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors: A Pilot Study

  2020cites this paper
• Diabetes Mellitus and Osteoporosis Correlation: Challenges and Hopes.

  2020cites this paper
• Wisp1 is a circulating factor that stimulates proliferation of adult mouse and human beta cells

  2020cites this paper
• The Interplay Between Bone and Glucose Metabolism

  2020cites this paper
• GLP-1 receptor agonists synergize with DYRK1A inhibitors to potentiate functional human β cell regeneration

  2020cites this paper
• Plasma osteoprotegerin as a biomarker of poor glycaemic control that predicts progression of albuminuria in type 2 diabetes mellitus: A 3-year longitudinal cohort study.

  2020cites this paper